BSE Live
Jan 27, 16:01Prev. Close
67.05
Open Price
66.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:58Prev. Close
66.40
Open Price
66.00
Bid Price (Qty.)
68.54 (165)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Bal Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 11 | Mar 10 | Mar 09 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 2.83 | 4.77 | 0.39 | -1.36 | 2.85 | |
| Diluted EPS (Rs.) | 2.80 | 4.60 | 0.39 | -1.36 | 2.85 | |
| Cash EPS (Rs.) | 8.22 | 8.83 | 3.16 | 1.36 | 4.72 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 42.86 | 45.04 | 34.51 | 34.11 | 35.52 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 42.86 | 45.04 | 34.51 | 34.11 | 35.52 | |
| Revenue from Operations/Share (Rs.) | 145.39 | 160.98 | 109.02 | 101.02 | 98.71 | |
| PBDIT/Share (Rs.) | 14.20 | 16.67 | 10.24 | 7.11 | 9.45 | |
| PBIT/Share (Rs.) | 8.74 | 12.40 | 7.47 | 4.38 | 7.65 | |
| PBT/Share (Rs.) | 3.68 | 5.96 | 0.99 | -1.02 | 3.90 | |
| Net Profit/Share (Rs.) | 2.76 | 4.56 | 0.39 | -1.36 | 2.85 | |
| NP After MI And SOA / Share (Rs.) | 2.82 | 4.56 | 0.39 | -1.36 | 2.85 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 9.76 | 10.35 | 9.38 | 7.03 | 9.57 | |
| PBIT Margin (%) | 6.01 | 7.70 | 6.85 | 4.33 | 7.75 | |
| PBT Margin (%) | 2.53 | 3.70 | 0.90 | -1.01 | 3.95 | |
| Net Profit Margin (%) | 1.89 | 2.83 | 0.35 | -1.34 | 2.89 | |
| NP After MI And SOA Margin (%) | 1.93 | 2.83 | 0.35 | -1.34 | 2.89 | |
| Return on Networth/Equity (%) | 6.57 | 10.13 | 1.12 | -3.99 | 8.03 | |
| Return on Capital Employed (%) | 5.07 | 7.46 | 0.40 | -2.26 | 4.58 | |
| Return on Assets (%) | 2.21 | 3.27 | 0.30 | -1.15 | 2.46 | |
| Total Debt/Equity (X) | 0.85 | 1.01 | 1.60 | 1.52 | 1.27 | |
| Asset Turnover Ratio (%) | 114.21 | 115.59 | 84.47 | 85.26 | 85.14 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.14 | 1.10 | 2.34 | 1.13 | 1.09 | |
| Quick Ratio (X) | 0.75 | 0.73 | 1.41 | 0.67 | 0.66 | |
| Inventory Turnover Ratio (X) | 5.23 | 5.64 | 3.55 | 3.70 | 4.33 | |
| Dividend Payout Ratio (NP) (%) | 35.48 | 21.90 | 0.00 | 0.00 | 26.27 | |
| Dividend Payout Ratio (CP) (%) | 12.08 | 11.32 | 0.00 | 0.00 | 15.88 | |
| Earnings Retention Ratio (%) | 64.52 | 78.10 | 0.00 | 0.00 | 73.73 | |
| Cash Earnings Retention Ratio (%) | 87.92 | 88.68 | 0.00 | 0.00 | 84.12 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 1.73 | 1.93 | 1.15 | 0.81 | 2.04 | |
| Interest Coverage Ratios (Post Tax) (%) | 1.73 | 1.93 | 1.15 | 0.81 | 2.04 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 127.37 | 82.53 | 79.87 | 81.89 | 61.17 | |
| EV/Net Operating Revenue (X) | 0.68 | 0.46 | 0.70 | 0.77 | 0.59 | |
| EV/EBITDA (X) | 6.97 | 4.46 | 7.44 | 10.99 | 6.17 | |
| MarketCap/Net Operating Revenue (X) | 0.46 | 0.19 | 0.21 | 0.27 | 0.15 | |
| Retention Ratios (%) | 64.51 | 78.09 | 0.00 | 0.00 | 73.72 | |
| Price/BV (X) | 1.56 | 0.70 | 0.67 | 0.81 | 0.41 | |
| Price/Net Operating Revenue | 0.46 | 0.19 | 0.21 | 0.27 | 0.15 | |
| Earnings Yield | 0.04 | 0.15 | 0.02 | -0.05 | 0.19 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y